| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e473613f549ad747f3af840e73fac8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate |
2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c9111d82fbc5583f47a2be0d98e428d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc443984dc2d349980809a1c5345bd9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e58b4d20548ffb314915fed58a978092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f21706a737ff79f43ff88129be11a7e |
| publicationDate |
2021-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202102220-A |
| titleOfInvention |
Toll-like receptor agonist dosing regimen |
| abstract |
Provided herein are formulations and methods of using a TLR-7 agonist for the treatment of hepatitis B virus infection. |
| priorityDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |